Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
Pharmacological Reviews|June 15, 2014
The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of diseaseRachael Bartlett, Leanne Stokes, Ronald SluyterBiochemical and Biophysical Research Communications|February 23, 2013
Human P2X7 receptor activation induces the rapid shedding of CXCL16Aleta Pupovac, Christopher M Foster, Ronald SluyterNeuropharmacology|December 4, 2022
P2X receptors: Insights from the study of the domestic dogRonald Sluyter, Reece A Sophocleous, Leanne StokesInternational Journal of Molecular Sciences|May 28, 2022
The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory TargetReece Andrew Sophocleous, Lezanne Ooi, Ronald SluyterImmunology and Cell Biology|April 9, 2019
Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host diseaseNicholas J Geraghty, Debbie Watson, Ronald SluyterMediators of Inflammation|February 23, 2013
P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microgliaRachael Bartlett, Justin J Yerbury, Ronald SluyterJournal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytesRonald Sluyter, Anne N Shemon, James S WileyBiochemical and Biophysical Research Communications|February 9, 2007
P2X(7) receptor activation causes phosphatidylserine exposure in human erythrocytesRonald Sluyter, Anne N Shemon, James S WileyImmunology and Cell Biology|November 30, 2006
Rottlerin inhibits P2X(7) receptor-stimulated phospholipase D activity in chronic lymphocytic leukaemia B-lymphocytesAnne N Shemon, Ronald Sluyter, James S WileyMethods in Molecular Biology (Clifton, N.J.)|March 18, 2025
Humanized Mouse Model of Graft-Versus-Host Disease Utilizing Nonirradiated NOD-scid-IL-2Rγ<sup>null</sup> MiceAmal Elhage, Chloe Sligar, Debbie Watson, et al.Pageof 12